Drug development report (6): An overview of phase I trials with new anticancer agents under the coordination and monitoring of the EORTC New Drug Development Office

G. Schwartsmann, I. J. Koier, J. Wanders, H. R. Hendriks, R. E C Henrar, L. Kalakun, H. M. Pinedo

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Drug development report (6): An overview of phase I trials with new anticancer agents under the coordination and monitoring of the EORTC New Drug Development Office'. Together they form a unique fingerprint.